Objective: To identify the sexual life problems among menopausal woman and to evaluate the levels of sexual life problems among menopausal woman. Methods: This study was conducted at maternity hospitals in Baghdad city to evaluate of sexual life problems among menopausal woman. This study was started in January 2021 to February 2021, The data regarding sexual life problems was achieved through the answering of women that attending maternity hospitals, the study consist of (200) women with menopausal age which were selected according to inclusion criteria (Women at menopausal age, Women with post-menopausal bleeding). The data are analyzed through the use of descriptive statistical analysis and inferential statistics. Results: most of women are showing unproblematic sexual life and only (23.5%) are showing problematic sexual life. presents the mean of scores for evaluation the items of sexual life among women at menopause age; the mean scores indicate unproblematic among most of the items except the items that are related to (suffering from reduced sexual activity; they had regular sexual relations; suffering from a lack of sexual desire; and they cannot give their husband's marital rights). Conclusion: Most of menopausal women are showing unproblematic sexual life and they have normal and joyful sexual life regardless they suffering from post-menopausal bleeding.
Background: Bleeding can happen in postmenopausal women for several reasons. Women on hormone replacement therapy, for example, can experience vaginal bleeding for a few months after starting the hormones. It's also possible for a woman who thought she'd gone through menopause to start ovulating again. Bleeding is a possibility if this happens. Postmenopausal bleeding can be caused by a range of different factors. Polyps, endometrial hyperplasia, and endometrial atrophy are all common triggers, abnormal bleeding can be considered for sequential (cyclical) regimens if a woman has heavy or persistent bleeding at the end of the progesterone process or after the progesterone phase, or if bleeding occurs at an unplanned time during the cycle. For women on tibolone or ongoing combined HRT combination the production of amenorrhea can take up to six months. Bleeding should also be considered rare in these women if it occurs after six months of treatment or if it occurs after the establishment of amenorrhea, In a menopausal woman, postmenopausal bleeding (PMB) refers to any uterine bleeding (other than the expected cyclic bleeding that occurs in women taking cyclic postmenopausal hormone therapy). Around 5 percent of office gynecology visits are accounted.Aims of the study: To evaluate bleeding characteristics among menopausal women and to assess women menstrual cycle and reproductive history.Methodology: This study was conducted at maternity hospitals in Baghdad city to evaluate of sexual life problems among menopausal woman. This study was started in January \ 2021 to February \ 2021, The data regarding sexual life problems was achieved through the answering of women that attending maternity hospitals, the study consist of (200) women with menopausal age which were selected according to inclusion criteria (Women at menopausal age, Women with post-menopausal bleeding). The data are analyzed through the use of descriptive statistical analysis and inferential statistics.Results: women are suffering of moderate post-menopausal bleeding as indicated by moderate mean scores among all items related to characteristics except item of “Bleeding with mucous material” that show high and item of “Bleeding occurs during sexual intercourse” that show low.Conclusion: Most of menopausal women are suffering of moderate post-menopausal bleeding.Recommendations: Health care facilities provide physical and psychological counseling for menopausal woman and their husbands educate menopausal woman and their husbands about special needs of woman with post-menopausal bleeding in their sexual life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.